Tango Therapeutics annual total assets
2020
2021
2022
2023
2024
2025
Tango Therapeutics Total Assets Growth & History (TNGX)
Tango Therapeutics's total assets was $398.7M for fiscal 2025.
View full Tango Therapeutics company overviewTango Therapeutics annual total assets history
| Fiscal year | Period ended | Total assets | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $398.7M | $82.2M | +25.97% |
| 2024 | 2024-12-31 | $316.5M | −$86.1M | −21.38% |
| 2023 | 2023-12-31 | $402.6M | −$33.9M | −7.77% |
| 2022 | 2022-12-31 | $436.5M | −$63.7M | −12.73% |
| 2021 | 2021-12-31 | $500.2M | $292.9M | +141.33% |
| 2020 | 2020-12-31 | $207.3M | — | — |
Tango Therapeutics quarterly total assets
Q3.20
Q4.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Total assets | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $1.07B | $836.0M | +351.42% |
| Q1 2026 | 2026-03-31 | $435.8M | $161.5M | +58.87% |
| Q4 2025 | 2025-12-31 | $398.7M | $82.2M | +25.97% |
| Q3 2025 | 2025-09-30 | $210.1M | −$142.3M | −40.37% |
| Q2 2025 | 2025-06-30 | $237.9M | −$143.6M | −37.64% |
| Q1 2025 | 2025-03-31 | $274.3M | −$131.9M | −32.47% |
| Q4 2024 | 2024-12-31 | $316.5M | −$86.1M | −21.38% |
| Q3 2024 | 2024-09-30 | $352.4M | −$75.8M | −17.70% |
| Q2 2024 | 2024-06-30 | $381.5M | $2.1M | +0.56% |
| Q1 2024 | 2024-03-31 | $406.2M | $2.4M | +0.61% |
| Q4 2023 | 2023-12-31 | $402.6M | −$33.9M | −7.77% |
| Q3 2023 | 2023-09-30 | $428.2M | −$36.0M | −7.75% |
| Q2 2023 | 2023-06-30 | $379.3M | −$69.1M | −15.40% |
| Q1 2023 | 2023-03-31 | $403.8M | −$67.8M | −14.37% |
| Q4 2022 | 2022-12-31 | $436.5M | −$63.7M | −12.73% |
| Q3 2022 | 2022-09-30 | $464.2M | −$66.0M | −12.45% |
| Q2 2022 | 2022-06-30 | $448.4M | $280.8M | +167.62% |
| Q1 2022 | 2022-03-31 | $471.5M | $303.3M | +180.23% |
| Q4 2021 | 2021-12-31 | $500.2M | $292.9M | +141.33% |
| Q3 2021 | 2021-09-30 | $530.1M | $361.8M | +214.84% |
| Q2 2021 | 2021-06-30 | $167.5M | — | — |
| Q1 2021 | 2021-03-31 | $168.3M | — | — |
| Q4 2020 | 2020-12-31 | $207.3M | — | — |
| Q3 2020 | 2020-09-30 | $168.4M | — | — |
Tango Therapeutics total assets trends
Over the last five fiscal years, Tango Therapeutics's total assets increased from $207.3M to $398.7M, a change of $191.4M. The latest reported quarter, Q2 2026, shows $1.07B.
About the metric
What total assets mean
Total assets are the resources a company controls at a reporting-period end, including cash, investments, receivables, inventory, property, intangible assets, and other reported assets. The composition of assets differs substantially by industry.
Calculation and source
SEC-reported total assets
TickerStat uses total assets reported in company SEC filings. When a filer provides the equivalent balance-sheet total as liabilities and equity, that reported amount is used because total assets must equal total liabilities plus equity. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Tango Therapeutics source filings ↗